The Feasibility of Florbetapir Quantitation
NCT01946243
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
96
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimers Disease
Interventions
DRUG:
Florbetapir F18
Sponsor
Avid Radiopharmaceuticals